Loading organizations...
Loading organizations...
Innovative cancer immunotherapies transforming treatment effectiveness.
Flashpoint Therapeutics has raised $10.0M across 1 funding round.
Flashpoint Therapeutics has raised $10.0M in total across 1 funding round.
Flashpoint Therapeutics has raised $10.0M in total across 1 funding round.
Flashpoint Therapeutics's investors include Abdulrahman Alolayan, Russell L. Carson.
Flashpoint Therapeutics has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Seed in October 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 25, 2023 | $10.0M Seed | Abdulrahman Alolayan | Russell L. Carson |